Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hyperion Therapeutics Inc

+ Add to Watchlist


46.0000 USD 0.0100 0.02%

As of 16:30:00 ET on 05/05/2015.

Company Profile for Hyperion Therapeutics Inc (HPTX)

Hyperion Therapeutics Inc. operates as a biopharmaceutical company. The Company develops therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion Therapeutics offers its services throughout the United States.

Contact Information

Hyperion Therapeutics Inc

2000 Sierra Point Parkway
Suite 400
Brisbane, CA 94005
United States
Phone: 1-650-745-7802
Fax: 1-650-871-7029

Key Executives for Hyperion Therapeutics Inc (HPTX)

Donald J SantelChief Executive OfficerJeffrey S FarrowChief Financial Officer
Bruce F ScharschmidtSenior VPChristine A NashSenior VP/Chief Commercial Ofcr
Ashley C GouldSenior VP:Governmental AffairsNatalie C HollesSenior VP:Corp Bus Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil